MedPath

INVO Bioscience

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
30
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)โ€ข Click on a phase to view related trials

Not Applicable
2 (100.0%)

3 Year Retrospective Analysis of IVF in Comparison With INVOcell

Conditions
Infertility
First Posted Date
2022-01-12
Last Posted Date
2022-01-12
Lead Sponsor
INVO Bioscience, Inc.
Target Recruit Count
450
Registration Number
NCT05189405
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Carolina Conceptions, Raleigh, North Carolina, United States

๐Ÿ‡บ๐Ÿ‡ธ

Piedmont Reproductive Endocrinology Group, Greenville, South Carolina, United States

๐Ÿ‡บ๐Ÿ‡ธ

CARE Fertility, Bedford, Texas, United States

and more 1 locations

Assessment of the INVOcell Culture Device When Used for up to Five-Day Incubation

Not Applicable
Completed
Conditions
Infertility
First Posted Date
2020-11-25
Last Posted Date
2021-02-17
Lead Sponsor
INVO Bioscience, Inc.
Target Recruit Count
31
Registration Number
NCT04644380
Locations
๐Ÿ‡บ๐Ÿ‡ธ

American Institute of Reproductive Medicine/IVF Alabama (AIRM), Homewood, Alabama, United States

Assessment of the INVOcell Intravaginal Culture System

Not Applicable
Suspended
Conditions
Infertility
First Posted Date
2020-01-29
Last Posted Date
2020-07-28
Lead Sponsor
INVO Bioscience, Inc.
Target Recruit Count
180
Registration Number
NCT04246268
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Piedmont Reproductive Endocrinology Group, West Columbia, South Carolina, United States

๐Ÿ‡บ๐Ÿ‡ธ

Fertility Center of San Antonio, San Antonio, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

The New Hope Center for Reproductive Medicine, Virginia Beach, Virginia, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.